Plus Therapeutics holds routine annual meeting, approves stock plan amendment

Filed May 15, 2026 · Period ending May 14, 2026 · ~1 min read

Key Changes

• medium

  Stockholders approved the sixth amendment to the 2020 Stock Incentive Plan, the most contested item with 7.98M votes for versus 5.65M against, potentially increasing shares available for employee compensation.

  Item 5.07 verify on EDGAR →
• low

  Six directors elected to one-year terms through 2027 annual meeting: Howard Clowes, An van Es-Johansson, Richard Hawkins, Marc Hedrick, Ronald Andrews, and Kyle Guse.

  Item 5.07 verify on EDGAR →
• low

  Stockholders ratified CBIZ CPAs as independent auditor for fiscal 2026 with 60.86M votes for, representing routine governance approval.

  Item 5.07 verify on EDGAR →